[1] |
Roos EM, Arden NK. Strategies for the prevention of knee osteoarthritis[J]. Nat Rev Rheumatol, 2016, 12(2): 92-101.
|
[2] |
Chouvarine P, Legchenko E, Geldner J, et al. Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle[J]. J Mol Med (Berl), 2019, 97(10): 1427-1438.
|
[3] |
Zhou Z, Tian F, An N, et al. MiR-300 serves as potential biomarker to screen knee osteoarthritis patients by targeting TNFα[J]. Clin Lab, 2018, 64(4): 577-584.
|
[4] |
Lai Z, Cao Y. Plasma miR-200c-3p, miR-100-5p, and miR-1826 serve as potential diagnostic biomarkers for knee osteoarthritis: randomized controlled trials[J/OL]. Medicine, 2019, 98(51): 18110-18116.
|
[5] |
Zhou JL, Fang HS, Peng H, et al. The relationship between HIF-2α and VEGF with radiographic severity in the primary osteoarthritic knee[J]. Yonsei Med J, 2016, 57(3): 735-740.
|
[6] |
Christine IS, Martinez-Sanchez A, Christopher LM. Derepression of MicroRNA-138 contributes to loss of the human articular chondrocyte phenotype[J]. Arthritis Rheumatol, 2016, 68(2): 398-409.
|
[7] |
Belo JN, Berger MY, Koes BW, et al. The prognostic value of the clinical ACR classification criteria of knee osteoarthritis for persisting knee complaints and increase of disability in general practice[J]. Osteoarthritis Cartilage, 2009, 17(10): 1288-1292.
|
[8] |
Özdemir M, Kavak R. Meniscal lesions in geriatric population: prevalence and association with knee osteoarthritis[J]. Curr Aging Sci, 2019, 12(1):67-73.
|
[9] |
Georgiev T, Angelov AK. Modifiable risk factors in knee osteoarthritis: treatment implications[J]. Rheumatol Int, 2019, 39(7):1145-1157.
|
[10] |
Panganiban RP, Wang Y, Howrylak J, et al. Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma[J]. J Allergy Clin Immunol, 2016, 137(5): 1423-1432.
|
[11] |
Rousseau JC, Millet M, Croset M, et al. Association of circulating microRNAs with prevalent and incident knee osteoarthritis in women: the OFELY study[J]. Arthritis Res Ther, 2020, 22(1):2-1432.
|
[12] |
Wan L, Zhao Q, Niu G, et al. Plasma miR-136 can be used to screen patients with knee osteoarthritis from healthy controls by targeting IL-17[J]. Exp Ther Med, 2018, 16(4): 3419-3424.
|
[13] |
Dou XJ, Zhang ZD, Wang S, et al. Combined use of serum miR-338-3p, cartilage oligomeric matrix protein and chondroitin sulfate-846 in the early diagnosis of knee osteoarthritis[J]. Clin Lab, 2019, 65(3): 319-324.
|
[14] |
Yin CM, Suen WC, Lin S, et al. Dysregulation of both miR-140-3p and miR-140-5p in synovial fluid correlate with osteoarthritis severity[J]. Bone Joint Res, 2017, 6(11): 612-618.
|
[15] |
Li B, Bai L, Shen P, et al. Identification of differentially expressed microRNAs in knee anterior cruciate ligament tissues surgically removed from patients with osteoarthritis[J]. Int J Mol Med, 2017, 40(4): 1105-1113.
|
[16] |
Zhou ZB, Du D, Huang GX, et al. Circular RNA Atp9b, a competing endogenous RNA, regulates the progression of osteoarthritis by targeting miR-138-5p[J]. Gene, 2018, 646(3): 203-209.
|
[17] |
Zhang FJ, Luo W, Lei GH. Role of HIF-1α and HIF-2α in osteoarthritis[J]. Joint Bone Spine, 2015, 82(3): 144-147.
|
[18] |
Yang Q, Zhou Y, Cai P, et al. Up-regulated HIF-2alpha contributes to the osteoarthritis development through mediating the primary cilia loss[J]. Int Immunopharmacol, 2019, 75(10): 105762-105768.
|
[19] |
Choi MC, Choi WH. Mithramycin a alleviates osteoarthritic cartilage destruction by inhibiting HIF-2α expression[J]. Int J Mol Sci, 2018, 19(5): 1411-1420.
|
[20] |
Li W, Cai L, Zhang Y, et al. Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1 and thereby silencing HIF-2α[J]. J Orthop Res, 2015, 33(7): 1061-1070.
|
[21] |
Wm O, Linklater JM, Hunter DJ. Imaging in knee osteoarthritis[J]. Curr Opin Rheumatol, 2017, 29(1): 86-95.
|